DOVIZIO, MELANIA
 Distribuzione geografica
Continente #
NA - Nord America 1.497
EU - Europa 1.359
AS - Asia 696
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
AF - Africa 1
Totale 3.560
Nazione #
US - Stati Uniti d'America 1.490
CN - Cina 306
IT - Italia 243
IE - Irlanda 240
SE - Svezia 204
SG - Singapore 189
UA - Ucraina 178
TR - Turchia 134
GB - Regno Unito 131
FR - Francia 93
DE - Germania 92
RU - Federazione Russa 49
FI - Finlandia 47
IN - India 44
CZ - Repubblica Ceca 41
BE - Belgio 16
PL - Polonia 12
VN - Vietnam 11
MX - Messico 6
GR - Grecia 4
JP - Giappone 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
AU - Australia 2
BR - Brasile 2
EU - Europa 2
IR - Iran 2
TW - Taiwan 2
AT - Austria 1
CA - Canada 1
CH - Svizzera 1
CO - Colombia 1
EE - Estonia 1
HR - Croazia 1
IL - Israele 1
NL - Olanda 1
SC - Seychelles 1
Totale 3.560
Città #
Chandler 292
Jacksonville 240
Dublin 233
Singapore 152
Southend 108
Princeton 105
Dearborn 91
Nanjing 85
Ashburn 77
Izmir 60
Chieti 55
Ann Arbor 54
Beijing 52
Altamura 47
Boardman 42
Cambridge 36
Santa Clara 36
Wilmington 36
Nanchang 31
Brno 25
Los Angeles 20
Shenyang 19
Munich 18
Hebei 17
Washington 17
Kunming 16
Olomouc 15
Brussels 14
Helsinki 14
Kocaeli 14
New York 13
Dong Ket 11
Kraków 11
Pescara 11
Spoltore 11
Woodbridge 11
Seattle 10
Jiaxing 9
Mumbai 9
Changsha 8
Milan 8
Tianjin 8
Hefei 7
Menlo Park 7
Shanghai 7
Augusta 6
Düsseldorf 6
Gavirate 6
Hangzhou 6
Ningbo 6
Rome 6
Torreón 6
Grevenbroich 5
Jinan 5
Lanzhou 5
San Mateo 5
Tappahannock 5
Tavagnacco 5
Torino 5
Kolkata 4
Norwalk 4
Taizhou 4
Xi'an 4
Bologna 3
Clearwater 3
Dubai 3
Falls Church 3
Genoa 3
Guangzhou 3
Houston 3
Tagara 3
Turin 3
Aberdeen 2
Athens 2
Avezzano 2
Changchun 2
Hanover 2
Leawood 2
Naples 2
Napoli 2
Orange 2
Padova 2
Redwood City 2
Simi Valley 2
São Paulo 2
Taichung 2
Vendelso 2
Viterbo 2
Worcester 2
Zhengzhou 2
Alba Adriatica 1
Amsterdam 1
Anzola Dell'emilia 1
Ardabil 1
Bergamo 1
Bhubaneswar 1
Campobasso 1
Cedar Knolls 1
Clifton 1
Cupertino 1
Totale 2.328
Nome #
Low-dose aspirin acetylates cyclooxygenase-1 in human colorectal mucosa: implications for the chemoprevention of colorectal cancer. 116
Reduced variability to aspirin antiplatelet effect by the coadministration of statins in high-risk patients for cardiovascular disease. 103
Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action 102
Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells. 99
Dysregulated post-transcriptional control of COX-2 gene expression in gestational diabetic endothelial cells 95
Mechanisms of the antitumoural effects of aspirin in the gastrointestinal tract. 89
Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro. 88
Platelet-specific deletion of cyclooxygenase-1 ameliorates dextran sulfate sodium-induced colitis in mice. 88
Platelet-Derived Microparticles From Obese Individuals: Characterization of Number, Size, Proteomics, and Crosstalk With Cancer and Endothelial Cells. 87
Rare SNP rs12731181 in the miR-590-3p Target Site of the Prostaglandin F2α Receptor Gene Confers Risk for Essential Hypertension in the Han Chinese Population. 86
Antithrombotic Agents and Cancer 84
Platelets as crucial partners for tumor metastasis: from mechanistic aspects to pharmacological targeting 83
Novel insights into the regulation of cyclooxygenase-2 expression by platelet-cancer cell cross-talk. 83
Dysregulation of gene expression in human fetal endothelial cells from gestational diabetes in response to TGF-β1 82
Induction of prostacyclin by steady laminar shear stress suppresses Tumor Necrosis Factor-alfa biosyntesis via Heme Oxygenase-1 in human endothelial cells. 78
Curbing tumorigenesis and malignant progression through the pharmacological control of the wound healing process. 78
Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors. 77
NCX 4040, a Nitric Oxide-Donating Aspirin, Exerts Anti-Inflammatory Effects through Inhibition of I{kappa}B-{alpha} Degradation in Human Monocytes. 77
Pharmacological inhibition of platelet-tumor cell cross-talk prevents platelet-induced overexpression of cyclooxygenase-2 in HT29 human colon carcinoma cells. 76
Mechanistic and pharmacological issues of aspirin as an anticancer agent 75
INDUCTION OF PROSTACYCLIN BY STEADY LAMINAR SHEAR STRESS SUPPRESSES TUMOR NECROSIS FACTOR-ALPHA BIOSYNTHESIS VIA HEME OXYGENASE-1 IN HUMAN ENDOTHELIAL CELLS. 74
Effects of celecoxib on prostanoid biosynthesis and circulating angiogenesis proteins in familial adenomatous polyposis. 74
Platelets and extracellular vesicles in cancer: diagnostic and therapeutic implications 74
Repeated exposure to codeine alters morphine glucuronidation by affecting UGT gene expression in the rat. 74
Novel insights into the vasoprotective role of heme oxygenase-1. 72
P2Y12 Receptors in Tumorigenesis and Metastasis 72
miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction. 72
Pharmacological Characterization of the Microsomal Prostaglandin E2 Synthase-1 Inhibitor AF3485 In Vitro and In Vivo 72
EFFECTS OF CELECOXIB ON SYSTEMIC MARKERS OF PROSTANOID GENERATION AND INFLAMMATION AND ANGIOGENESIS IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS: A BIOMARKER CLINICAL STUDY. 70
In vitro morphine metabolism by rat microglia. 69
Platelets, cyclooxygenases, and colon cancer. 69
Novel analgesic/anti-inflammatory agents: 1,5-diarylpyrrole nitrooxyalkyl ethers and related compounds as cyclooxygenase-2 inhibiting nitric oxide donors. 64
EFFECTS OF NCX-2057, A NITRIC OXIDE-RELEASING DERIVATIVE OF THE NATURAL ANTIOXIDANT FERULIC ACID, ON HUMAN PLATELET AND MONOCYTE EICOSANOID PATHWAYS IN VITRO. 63
An aquaporin-4/transient receptor potential vanilloid 4 (AQP4/TRPV4) complex is essential for cell-volume control in astrocytes. 63
Role of Platelets in Inflammation and Cancer: Novel Therapeutic Strategies 63
Molecular and Experimental Basis for COX inhibition in cancer 60
Carbenoxolone inhibits volume-regulated anion conductance in cultured rat cortical astroglia. 59
Time for Integrating Clinical, Lifestyle and Molecular Data to Predict Drug Responses 59
Platelets in cancer development and diagnosis. 59
COX-2 and EGFR: Partners in Crime Split by Aspirin 57
Pharmacological characterization of the biosynthesis of prostanoids and hydroxyeicosatetraenoic acids in human whole blood and platelets by targeted chiral lipidomics analysis 55
Mode of action of aspirin as a chemopreventive agent. 54
Inside platelet-leukocyte cross-talk 53
Low-dose Aspirin prevents hypertension and cardiac fibrosis when thromboxane A2 is unrestrained 51
Platelets induce free and phospholipid-esterified 12-hydroxyeicosatetraenoic acid generation in colon cancer cells by delivering 12-lipoxygenase 51
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors. 49
Multifaceted Functions of Platelets in Cancer: From Tumorigenesis to Liquid Biopsy Tool and Drug Delivery System 49
The antiplatelet agent revacept prevents the increase of systemic thromboxane A2 biosynthesis and neointima hyperplasia 47
Characterization of cyclooxygenase-2 acetylation and prostanoid inhibition by aspirin in cellular systems 44
Real world evidence: patients with alopecia areata in Italy 40
Expression and functional characterization of the large-conductance calcium and voltage-activated potassium channel K ca 1.1 in megakaryocytes and platelets 33
Biology and pharmacology of platelet-type 12-lipoxygenase in platelets, cancer cells, and their crosstalk 32
Biomarkers of Response to Low-Dose Aspirin in Familial Adenomatous Polyposis Patients 27
Tumor-Educated Platelet Extracellular Vesicles: Proteomic Profiling and Crosstalk with Colorectal Cancer Cells 27
A retrospective analysis of treatment patterns, drug discontinuation and healthcare costs in Crohn's disease patients treated with biologics 20
Heart failure and economic impact: an analysis in real clinical practice in Italy [Scompenso cardiaco e impatto economico: un’analisi nella reale pratica clinica in Italia] 20
Polystyrene nanoplastics mediate oxidative stress, senescence, and apoptosis in a human alveolar epithelial cell line 20
Healthcare Resource Consumption and Related Costs in Patients on Antiretroviral Therapies: Findings from Real-World Data in Italy 18
Real-World Data Analysis of Patients Affected by Immune-Mediated Thrombotic Thrombocytopenic Purpura in Italy 18
Estimation of patients with psoriasis potentially eligible and currently untreated with biological drugs in Italy 17
Real-World Treatment Patterns and Healthcare Resource Use for Ulcerative Colitis and Crohn’s Disease in Italy 16
Anticoagulation in atrial fibrillation. A large real-world update 15
Evaluation of the Impact of Catheter Ablation Procedure on Outcomes and Economic Burden in Patients with Atrial Fibrillation: Real-World Data from Italian Administrative Databases 14
Retrospective Analysis of the Pharmaco-Utilization of VEGF Inhibitors and Health Care Costs among Patients with Wet Age-Related Macular Degeneration and Other Ocular Diseases in Italy 14
Estimation of patients affected by inflammatory bowel disease potentially eligible for biological treatment in a real-world setting 13
Analysis of Patients’ Characteristics and Treatment Profile of People Who Use Drugs (PWUDs) with and without a Co-Diagnosis of Viral Hepatitis C: A Real-World Retrospective Italian Analysis 12
Incidence and Predictors of Switching and Dose Change of Direct Oral Anticoagulants among Elderly Patients with Nonvalvular Atrial Fibrillation: A 5-Year Analysis of a Large Administrative Database 12
Analysis of the Pharmacoutilization of Biological Drugs in Psoriatic Arthritis Patients: A Real-World Retrospective Study Among an Italian Population 12
Differential Adherence to Free and Single-Pill Combination of Rosuvastatin/Ezetimibe: Findings from a Real-World Analysis in Italy 11
Patients with HR+/HER2- metastatic breast cancer treated with CDK4/6 inhibitors: a real-world study in Italy 11
Analysis of Patients with Focal Epilepsy and Drug-Resistant Epilepsy in Italy: Evaluation of Their Characteristics, Therapeutic Pathway and the Consumption of Healthcare Resources 10
Hypertriglyceridemia is associated with decline of estimated glomerular filtration rate and risk of end-stage kidney disease in a real-word Italian cohort: Evidence from the TG-RENAL Study 9
Real-World Evaluation of Calcimimetics for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease, in an Italian Clinical Setting 9
The Influence of Iron-Deficiency Anaemia (IDA) Therapy on Clinical Outcomes and Healthcare Resource Consumptions in Chronic Kidney Disease Patients Affected by IDA: A Real-Word Evidence Study among the Italian Population 9
Clinical and economic burden of respiratory syncytial virus in children aged 0–5 years in Italy 8
Analysis of outcomes and healthcare resource consumption in patients with ANCA-associated vasculitis in a setting of clinical practice in Italy.|Analisi degli outcome e del consumo di risorse sanitarie in pazienti con vasculite ANCA-associata in un contesto di pratica clinica in Italia 8
Real-World Analysis of Outcomes and Economic Burden in Patients with Chronic Kidney Disease with and without Secondary Hyperparathyroidism among a Sample of the Italian Population 7
Profile, Healthcare Resource Consumption and Related Costs in ANCA-Associated Vasculitis Patients: A Real-World Analysis in Italy 4
The economic impact of different blood glucose monitoring systems in the diabetic patient: Analysis of real-world data from an Italian local health authority 2
Totale 4.006
Categoria #
all - tutte 17.144
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.144


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020430 0 0 13 9 58 57 95 50 37 44 57 10
2020/2021403 43 3 47 5 18 55 16 32 68 47 26 43
2021/2022274 1 6 11 73 10 5 6 21 23 15 29 74
2022/2023826 65 148 56 77 59 154 49 65 119 8 16 10
2023/2024603 26 22 36 16 35 111 97 17 6 61 28 148
2024/2025402 144 258 0 0 0 0 0 0 0 0 0 0
Totale 4.006